CMR and adverse clinical outcomes in peripartum cardiomyopathy
Agnes Koczo(University of Pittsburgh Medical Center), Timothy C. Wong(University of Pittsburgh), Uri Elkayam(Icahn School of Medicine at Mount Sinai), Dennis M. McNamara(University of Pittsburgh Medical Center), Erik B. Schelbert(University of Pittsburgh), Michael M. Givertz(Brigham and Women's Hospital), Rami Alharethi(Intermountain Medical Center), Deeksha Acharya(University of Pittsburgh Medical Center), Benay Özbay(University of Pittsburgh Medical Center)
American Heart Journal Plus Cardiology Research and Practice
November 9, 2024
Cited by 1
Related Papers
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies
|New England Journal of Medicine|2016|597